Report overview
Swine flu is infection of the respiratory system caused by influenza viruses. These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior. Influenza viruses can also be transmitted to humans. Swine flu viruses can induce genetic changes or mutations so that these are easily transmissible among humans.
This report aims to provide a comprehensive presentation of the global market for Swine Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Flu Vaccine. This report contains market size and forecasts of Swine Flu Vaccine in global, including the following market information:
Global Swine Flu Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Swine Flu Vaccine Market Sales, 2018-2023, 2024-2030, (K Dose)
Global top five Swine Flu Vaccine companies in 2022 (%)
The global Swine Flu Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Intradermal Vaccination Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Swine Flu Vaccine include Novartis, CSL Limited, Zydus Cadila, AstraZeneca, GlaxoSmithKline, Sanofi, Baxter and Sinovac Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Swine Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Flu Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Swine Flu Vaccine Market Segment Percentages, by Type, 2022 (%)
Intradermal Vaccination
Intramuscular Vaccination
Subcutaneous Vaccination
Others
Global Swine Flu Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Swine Flu Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Clinic And Vaccination Centers
Global Swine Flu Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Swine Flu Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Flu Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Swine Flu Vaccine revenues share in global market, 2022 (%)
Key companies Swine Flu Vaccine sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Swine Flu Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
CSL Limited
Zydus Cadila
AstraZeneca
GlaxoSmithKline
Sanofi
Baxter
Sinovac Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Flu Vaccine, market overview.
Chapter 2: Global Swine Flu Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Swine Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Swine Flu Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
